Understanding how radiation affects gut immune cells
Radiation-Induced Paneth Cell Dysfunction
This study is looking at how radiation affects the immune system in the gut, especially the cells that help fight off infections, to find ways to protect people from health problems caused by radiation exposure.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tennessee Health Sci Ctr NIH-funded |
| Lab location | 1 site (Memphis, United States) |
| Project ID | NIH-11094856 on NIH RePORTER |
What this research studies
This research investigates the impact of radiation exposure on the gut's immune system, particularly focusing on Paneth cells that produce antibacterial peptides. By exploring the mechanisms of radiation-induced immune dysfunction, the study aims to identify potential medical countermeasures to protect against acute radiation syndrome (ARS). The approach includes examining how radiation alters gut microbiota and contributes to systemic inflammation, which can lead to severe health complications. Patients may benefit from insights that could lead to new treatments for radiation exposure.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who may be at risk of radiation exposure, such as first responders or patients undergoing radiation therapy.
Not a fit: Patients who have not been exposed to radiation or those with unrelated gastrointestinal conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective therapies for patients suffering from acute radiation syndrome.
How similar studies have performed: Previous research has shown promise in understanding immune responses to radiation, but this specific focus on Paneth cells and their role in ARS is relatively novel.
Where this research is happening
Memphis, United States
- University of Tennessee Health Sci Ctr — Memphis, United States (Active)
Researchers
- Principal investigator: Rao, Radhakrishna — University of Tennessee Health Sci Ctr
- Study coordinator: Rao, Radhakrishna
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.